van Genderingen Joep, Nguyen Dan, Knuth Franziska, Nomer Hazem A A, Incrocci Luca, Sharfo Abdul Wahab M, Zolnay András, Oelfke Uwe, Jiang Steve, Rossi Linda, Heijmen Ben J M, Breedveld Sebastiaan
Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, the Netherlands.
UT Southwestern Medical Center, Medical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, Dallas, USA.
Radiother Oncol. 2025 Feb;203:110662. doi: 10.1016/j.radonc.2024.110662. Epub 2024 Dec 6.
Fast, high-quality deep learning (DL) prediction of patient-specific 3D dose distributions can enable instantaneous treatment planning (IP), in which the treating physician can evaluate the dose and approve the plan immediately after contouring, rather than days later. This would greatly benefit clinical workload, patient waiting times and treatment quality. IP requires that predicted dose distributions closely match the ground truth. This study examines how training dataset size and model size affect dose prediction accuracy for Erasmus-iCycle GT plans to enable IP.
For 1250 prostate patients, dose distributions were automatically generated using Erasmus-iCycle. Hierarchically Densely Connected U-Nets with 2/3/4/5/6 pooling layers were trained with datasets of 50/100/250/500/1000 patients, using a validation set of 100 patients. A fixed test set of 150 patients was used for evaluations.
For all model sizes, prediction accuracy increased with the number of training patients, without levelling off at 1000 patients. For 4-6 level models with 1000 training patients, prediction accuracies were high and comparable. For 6 levels and 1000 training patients, the median prediction errors and interquartile ranges for PTV V, rectum V and bladder V were 0.01 [-0.06,0.15], 0.01 [-0.20,0.29] and -0.02 [-0.27,0.27] %-point. Dose prediction times were around 1.2 s.
Although even for 1000 training patients there was no convergence in obtained prediction accuracy yet, the accuracy for the 6-level model with 1000 training patients may be adequate for the pursued instantaneous planning, which is subject of further research.
对患者特定的三维剂量分布进行快速、高质量的深度学习(DL)预测能够实现即时治疗计划(IP),即治疗医师在勾画轮廓后可立即评估剂量并批准计划,而非数日后进行。这将极大地有益于临床工作量、患者等待时间及治疗质量。即时治疗计划要求预测的剂量分布与真实情况紧密匹配。本研究探讨训练数据集大小和模型大小如何影响伊拉斯谟-iCycle GT计划的剂量预测准确性,以实现即时治疗计划。
对于1250例前列腺癌患者,使用伊拉斯谟-iCycle自动生成剂量分布。使用包含50/100/250/500/1000例患者的数据集,对具有2/3/4/5/6个池化层的分层密集连接U-Net进行训练,使用100例患者的验证集。使用150例患者的固定测试集进行评估。
对于所有模型大小,预测准确性随训练患者数量的增加而提高,在1000例患者时并未趋于平稳。对于具有1000例训练患者的4 - 6层模型,预测准确性较高且相当。对于6层和1000例训练患者,PTV V、直肠V和膀胱V的预测误差中位数和四分位间距分别为0.01[-0.06,0.15]、0.01[-0.20,0.29]和 - 0.02[-0.27,0.27]百分点。剂量预测时间约为1.2秒。
尽管即使对于1000例训练患者,获得的预测准确性仍未收敛,但具有1000例训练患者的6层模型的准确性可能足以满足所追求的即时计划,这有待进一步研究。